Intensive care beds in Germany
SKU:
$1,990.00
$1,990.00
per item
Description
In 2013 there were officially 1,996 clinics with around 500,700 hospital beds. Of these clinics, approximately 60% are equipped with intensive care beds. Despite the decreasing number of clinics and beds, due to the increasing consolidation in the clinic market, the number of intensive care beds is constantly increasing. About 19% of intensive care units are privately owned. Due to increasing occupancy days in intensive care units and an increase in patient numbers, this submarket of hospital beds can be regarded as a growth market.
The Qnidos Deutsche Health Intelligence "Intensive Care in Germany" offers managers of service providers and manufacturers a comprehensive insight into current and future market conditions. The focus of the market investigation is on the detailed presentation of the annual sales potential of intensive care units in hospitals. The results of this study are based on the Qnidos Deutsche Health Intelligence for Intensive Care Units in 377 hospitals.
In addition to describing the competitive situation of manufacturers, the study also provides an overview of the reimbursement system for hospital beds.
In addition to a detailed growth forecast for the next five years, the study answers the following questions concerning intensive care services in Germany:
How has the number of clinics and hospital beds developed in Germany?
Which locations and features are available?
What is the potential for sales according to equipment features / price segments?
How is the Intensive Care Fund financed?
What is the importance of purchasing groups?
Where do the purchasing communities position themselves with regard to their members?
Where do market players position themselves with regard to their product portfolio?
The Qnidos Deutsche Health Intelligence "Intensive Care in Germany" offers managers of service providers and manufacturers a comprehensive insight into current and future market conditions. The focus of the market investigation is on the detailed presentation of the annual sales potential of intensive care units in hospitals. The results of this study are based on the Qnidos Deutsche Health Intelligence for Intensive Care Units in 377 hospitals.
In addition to describing the competitive situation of manufacturers, the study also provides an overview of the reimbursement system for hospital beds.
In addition to a detailed growth forecast for the next five years, the study answers the following questions concerning intensive care services in Germany:
How has the number of clinics and hospital beds developed in Germany?
Which locations and features are available?
What is the potential for sales according to equipment features / price segments?
How is the Intensive Care Fund financed?
What is the importance of purchasing groups?
Where do the purchasing communities position themselves with regard to their members?
Where do market players position themselves with regard to their product portfolio?
